LSE Capital approves participation in JV arrangement for Sindh healthcare project
Scheme / ArrangementLSE Capital Limited’s Board approved the company’s participation in a joint venture arrangement with LABLINK Enterprises to pre-qualify and bid for a Sindh provincial project supplying medical, healthcare and surgical products and equipment, including NIPRO and Baxter products.
Key Findings
- The Board approved LSE Capital’s participation in a joint venture with LABLINK Enterprises.
- The proposed activity involves pre-qualification and bidding for a project of the Province of Sindh.
- LABLINK is described as a registered sole proprietorship engaged in importing, distributing and supplying medical, healthcare and surgical products and equipment.
- The disclosure does not state that the bid has been submitted or that the project has been awarded.
Disclosure Details
Entities Involved
LSE Capital Limited, LABLINK Enterprises, Province of Sindh, NIPRO, Baxter
Impact
LSE Capital will participate in a joint venture arrangement to pre-qualify and bid for a provincial healthcare supply project; no award or financial value is disclosed.
Risks
The project outcome depends on pre-qualification and bidding; no contract award is reported.
⚡
Highlights summarize the key points from the company's official PSX filing. View the original filing for the complete details before making financial decisions.


